Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery

NCT ID: NCT02385344

Last Updated: 2018-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1046 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-04-30

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the registry is to collect information regarding the number and type of coronary artery bypass (CAB) surgical procedure changes that are made based on intraoperative guidance information using transit time flow measurements (TTFM) and ultrasound image capabilities provided with the Medistim device.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Bypass

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medistim device

This registry is intended to document surgical findings, procedural changes, and adverse events occurring prior to discharge

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has been scheduled for coronary bypass surgery
* Subject understands the nature of the procedure and has signed the subject informed consent prior to the procedure
* Subject has been diagnosed with 2-3 vessel disease

Exclusion Criteria

* Subject is scheduled for other surgical procedures during the bypass surgery (valve replacement/repair, carotid endarterectomy, etc.)
* Subject is known to be suffering from any psychological, developmental, physical, or emotional disorder that the investigator feels would interfere with surgery or follow-up testing
* Subject is undergoing an emergency cardiac bypass surgery
* Subject has history or presence of muscle disease (i.e. myopathy, myalgia, myasthenia, rhabdomyolysis) with or without concomitant CK-elevation \> 5 ULN that cannot be ascribed to any other medical condition (e.g. myocardial infarction)
* Subject has any condition that the investigator believes should exclude him/her from this registry
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medistim ASA

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne Waaler, MSc Pharm

Role: STUDY_DIRECTOR

Medistim ASA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Veterans Affairs Medical Center

Washington DC, Maryland, United States

Site Status

Mount Sinai Beth Israel

New York, New York, United States

Site Status

University of Calgary

Calgary, Alberta, Canada

Site Status

University of Duisburg-Essen, Dept. of Cardiothoracic Surgery

Essen, , Germany

Site Status

Clinica Cardiochirurgica

Chieti, , Italy

Site Status

Erasmus University Medical Center

Rotterdam, , Netherlands

Site Status

University of Oxford

Oxford, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada Germany Italy Netherlands United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Leviner DB, von Mucke Similon M, Rosati CM, Amabile A, Thuijs DJFM, Giammarco GD, Wendt D, Trachiotis GD, Kieser TM, Kappetein AP, Head SJ, Taggart DP, Puskas JD. Transit time flow measurement of coronary bypass grafts before and after protamine administration. J Cardiothorac Surg. 2021 Jul 9;16(1):195. doi: 10.1186/s13019-021-01575-y.

Reference Type DERIVED
PMID: 34243799 (View on PubMed)

Rosenfeld ES, Trachiotis GD, Napolitano MA, Sparks AD, Wendt D, Kieser TM, Puskas JD, DiGiammarco G, Taggart DP. Intraoperative transit-time flow measurement and high-frequency ultrasound in coronary artery bypass grafting: impact in off versus on-pump, arterial versus venous grafting and cardiac territory grafted. Eur J Cardiothorac Surg. 2021 Dec 27;61(1):204-213. doi: 10.1093/ejcts/ezab239.

Reference Type DERIVED
PMID: 34166508 (View on PubMed)

Rosenfeld ES, Trachiotis GD, Sparks AD, Napolitano MA, Lee KB, Wendt D, Kieser TM, Puskas JD, DiGiammarco G, Taggart DP. Intraoperative surgical strategy changes in patients with chronic and end-stage renal disease undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 2021 Jun 14;59(6):1210-1217. doi: 10.1093/ejcts/ezab104.

Reference Type DERIVED
PMID: 33675642 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1501

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit
NCT06434935 ENROLLING_BY_INVITATION EARLY_PHASE1